Southern Acids (M)

Equities

SAB

MYL5134OO001

Commodity Chemicals

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
3.35 MYR -1.47% Intraday chart for Southern Acids (M) +3.08% +6.35%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Southern Acids (M) Berhad Announces Production Results for the Month of March 2024 CI
Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director CI
Southern Acids (M) Berhad Announces Production Results for the Month of February 2024 CI
Southern Acids (M) Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee CI
Southern Acids (M) Berhad Announces Cessation of Office of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Member of Audit Committee CI
Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Chairman of Audit Committee to Independent and Non Executive Member of Audit Committee CI
Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Member of Audit Committee CI
Southern Acids (M) Berhad Reports Production Results for the Month of January 2024 CI
Southern Acids (M) Berhad Reports Production Results for the Month of December 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of November 2023 CI
Southern Acids (M) Berhad Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of October 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of September 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of August 2023 CI
Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director CI
Southern Acids' Profit Declines in Fiscal Q1 MT
Southern Acids (M) Berhad Reports Property, Plant and Equipment Written Off for the First Quarter Ended June 30, 2023 CI
Southern Acids (M) Berhad Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of July 2023 CI
Southern Acids (M) Berhad Proposes Single Tier Final Dividend for the Financial Year Ended 31 March 2023, Payable on 4 October 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of June 2023 CI
Southern Acids to Seek Shareholder Nod to Renew Buyback, Transaction Authority MT
Southern Acids (M) Berhad Announces Production Results for the Month of May 2023 CI
Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee CI
Chart Southern Acids (M)
More charts
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products. The Company operates through three segments: Oleochemical, Milling & Estate, and Healthcare. The Oleochemical segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The manufacturing plant is located in Kapar, Klang, which has an annual manufacturing capacity of approximately 100,000 metric tons (MT). The Milling & Estate Segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (POM) and palm kernel, as well as oil palm cultivation. It operates two POM located in Riau, Indonesia with a combined milling capacity of 100 MT per hour. The Healthcare Segment operates Sri Kota Specialist Medical Centre (Sri Kota), a 232-bedded private tertiary hospital located in Klang, Selangor.
More about the company
  1. Stock Market
  2. Equities
  3. SAB Stock
  4. News Southern Acids (M)
  5. Southern Acids' Profit Declines in Fiscal Q1